Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery

Bibliography

• Cheishvili D, Boureau L, Szyf M. DNA demethylation and invasive cancer: Implications for therapeutics. Br J Pharmacol 2015;172(11):2705-15
   PubMed Web of Science ®Google Scholar
• Rius M, Lyko F. Epigenetic cancer therapy: Rationales, targets and drugs. Oncogene 2012;31(39):4257-65
   PubMed Web of Science ®Google Scholar
• Romier C, Wurtz J-M, Renaud J-P, et al. Structural biology of epigenetic targets. In: Sippl W, Jung M, editors. Structural biology of epigenetic targets. Wiley-VCH; Weinheim: 2009. p. 23-56
   Google Scholar
• Choi SH, Heo K, Byun H-M, et al. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res 2011;39(1):104-18
   PubMed Web of Science ®Google Scholar
• Chen T, Hevi S, Gay F, et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 2007;39(3):391-6
   PubMed Web of Science ®Google Scholar
• Jia D, Jurkowska RZ, Zhang X, et al. Structure of DNMT3a bound to DNMT3L suggests a model for de novo DNA methylation. Nature 2007;449(7159):248-51
   PubMed Web of Science ®Google Scholar
• Erdmann A, Halby L, Fahy J, et al. Targeting DNA methylation with small molecules: What’s next? J Med Chem 2015;58(6):2569-83
   PubMed Web of Science ®Google Scholar
• Gros C, Fahy J, Halby L, et al. DNA methylation inhibitors in cancer: Recent and future approaches. Biochimie 2012;94(11):2280-96
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL, Méndez-Lucio O, Yoo J, et al. Discovery and development of DNA methyltransferase inhibitors using in silico approaches. Drug Discov Today 2015;20(5):569-77
   PubMed Web of Science ®Google Scholar
• Chen SJ, Wang YL, Zhou W, et al. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening. J Med Chem 2014;57(21):9028-41
   PubMed Web of Science ®Google Scholar
• Méndez-Lucio O, Tran J, Medina-Franco JL, et al. Towards drug repurposing in epigenetics: Olsalazine as a novel hypomethylating compound active in a cellular context. ChemMedChem 2014;9:560-5
   PubMed Web of Science ®Google Scholar
• Gaulton A, Bellis LJ, Bento AP, et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res 2012;40(D1):D1100-D07
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL, Caulfield T. Advances in the computational development of DNA methyltransferase inhibitors. Drug Discov Today 2011;16(9-10):418-25
   PubMed Web of Science ®Google Scholar
• Yoo J, Medina-Franco JL. Homology modeling, docking, and structure-based pharmacophore of inhibitors of DNA methyltransferase. J Comp-Aided Mol Des 2011;25(6):555-67
   PubMed Web of Science ®Google Scholar
• Song J, Rechkoblit O, Bestor TH, et al. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 2011;331(6020):1036-40
   PubMed Web of Science ®Google Scholar
• Medina-Franco J, Méndez-Lucio O, Yoo J. Rationalization of activity cliffs of a sulfonamide inhibitor of DNA methyltransferases with induced-fit docking. Int J Mol Sci 2014;15(2):3253-61
   PubMed Web of Science ®Google Scholar
• Bajorath J. Modeling of activity landscapes for drug discovery. Expert Opin Drug Discovery 2012;7(6):463-73
   PubMed Web of Science ®Google Scholar
• Wawer M, Lounkine E, Wassermann AM, et al. Data structures and computational tools for the extraction of SAR information from large compound sets. Drug Discov Today 2010;15(15-16):630-9
   PubMed Web of Science ®Google Scholar
• Guha R. Exploring structure–activity data using the landscape paradigm. Wiley Interdiscip Rev Comput Mol Sci 2012;2(6):829-41
   Web of Science ®Google Scholar
• Waddell J, Medina-Franco JL. Bioactivity landscape modeling: Chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets. Bioorg Med Chem 2012;20(18):5443-52
   PubMed Web of Science ®Google Scholar
• Guha R. Exploring uncharted territories: Predicting activity cliffs in structure–activity landscapes. J Chem Inf Model 2012;52(8):2181-91
   PubMed Web of Science ®Google Scholar
• Santos R, Giulianotti MA, Houghten RA, et al. Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. J Chem Inf Model 2013;53(10):2613-25
   PubMed Web of Science ®Google Scholar
• Heikamp K, Hu X, Yan A, et al. Prediction of activity cliffs using support vector machines. J Chem Inf Model 2012;52(9):2354-65
   PubMed Web of Science ®Google Scholar
• Maggiora GM. On outliers and activity cliffs-why QSAR often disappoints. J Chem Inf Model 2006;46(4):1535
   PubMed Web of Science ®Google Scholar
• Stumpfe D, Hu Y, Dimova D, et al. Recent progress in understanding activity cliffs and their utility in medicinal chemistry. J Med Chem 2014;57(1):18-28
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL, Yongye AB, López-Vallejo F. Consensus models of activity landscapes. In: Matthias D, Kurt V, Danail B, editors. Statistical modeling of molecular descriptors in QSAR/QSPR. Wiley-VCH, Weinheim, Germany; 2012. p. 307-26
   Google Scholar
• Martínez-Mayorga K, Medina-Franco JL. Chemoinformatics—applications in food chemistry. In: Taylor S, editor. Advances in food and nutrition research. Academic Press; Burlington: 2009. p. 33-56
   Google Scholar
• Martínez-Mayorga K, Peppard TL, Yongye AB, et al. Characterization of a comprehensive flavor database. J Chemometr 2011;25(10):550-60
   Web of Science ®Google Scholar
• Cruz-Monteagudo M, Medina-Franco JL, Pérez-Castillo Y, et al. Activity cliffs in drug discovery: Dr. Jekyll or Mr. Hyde? Drug Discovery Today 2014;19(8):1069-80
   PubMed Web of Science ®Google Scholar
• Guha R, Van Drie JH. Assessing how well a modeling protocol captures a structure-activity landscape. J Chem Inf Model 2008;48(8):1716-28
   PubMed Web of Science ®Google Scholar
• Golbraikh A, Muratov E, Fourches D, et al. Data set modelability by QSAR. J Chem Inf Model 2014;54(1):1-4
   PubMed Web of Science ®Google Scholar
• Mendez-Lucio O, Perez-Villanueva J, Castillo R, et al. Identifying activity cliff generators of PPAR ligands using SAS maps. Mol Inf 2012;31(11-12):837-46
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL. Scanning structure–activity relationships with structure–activity similarity and related maps: From consensus activity cliffs to selectivity switches. J Chem Inf Model 2012;52(10):2485-93
   PubMed Web of Science ®Google Scholar
• Iyer P, Stumpfe D, Vogt M, et al. Activity landscapes, information theory, and structure - activity relationships. Mol Inf 2013;32(5-6):421-30
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram V, Maggiora GM. Characterizing property and activity landscapes using an information-theoretic approach CINF-032. 222nd ACS National Meeting, Chicago, IL, United States: American Chemical Society, Washington, DC; 2001
   Google Scholar
• Pérez-Villanueva J, Santos R, Hernández-Campos A, et al. Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem 2010;18(21):7380-91
   PubMed Web of Science ®Google Scholar
• Méndez-Lucio O, Kooistra AJ, Graaf C, et al. Analysing multitarget activity landscapes using protein-ligand interaction fingerprints: Interaction cliffs. J Chem Inf Mod 2015;55(2):251-62
   PubMed Web of Science ®Google Scholar
• Guha R, VanDrie JH. Structure-activity landscape index: Identifying and quantifying activity cliffs. J Chem Inf Model 2008;48(3):646-58
   PubMed Web of Science ®Google Scholar
• Willett P. Combination of similarity rankings using data fusion. J Chem Inf Mod 2013;53(1):1-10
   PubMed Web of Science ®Google Scholar
• Durant JL, Leland BA, Henry DR, et al. Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci 2002;42(6):1273-80
   PubMedGoogle Scholar
• Rogers D, Hahn M. Extended-connectivity fingerprints. J Chem Inf Model 2010;50(5):742-54
   PubMed Web of Science ®Google Scholar
• Hu X, Hu Y, Vogt M, et al. MMP-cliffs: Systematic identification of activity cliffs on the basis of matched molecular pairs. J Chem Inf Model 2012;52(5):1138-45
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL, Martínez-Mayorga K, Bender A, et al. Characterization of activity landscapes using 2D and 3D similarity methods: Consensus activity cliffs. J Chem Inf Model 2009;49(2):477-91
   PubMed Web of Science ®Google Scholar
• Yongye A, Byler K, Santos R, et al. Consensus models of activity landscapes with multiple chemical, conformer and property representations. J Chem Inf Model 2011;51(6):1259-70
   PubMed Web of Science ®Google Scholar
• Medina-Franco JL. Activity cliffs: Facts or artifacts? Chem Biol Drug Des 2013;81(5):553-6
   PubMed Web of Science ®Google Scholar
• Rojas-Aguirre Y, Medina-Franco J. Analysis of structure-CACO-2 permeability relationships using a property landscape approach. Mol Diversity 2014;18(3):599-610
   PubMed Web of Science ®Google Scholar
• Cacabelos R, Torrellas C. Epigenetic drug discovery for Alzheimer’s disease. Expert Opin Drug Discovery 2014;9(9):1059-86
   PubMed Web of Science ®Google Scholar
• Dhanak D, Jackson P. Development and classes of epigenetic drugs for cancer. Biochem Biophys Res Commun 2014;455(1-2):58-69
   PubMed Web of Science ®Google Scholar
• Loetsch J, Schneider G, Reker D, et al. Common non-epigenetic drugs as epigenetic modulators. Trends Mol Med 2013;19(12):742-53
   PubMed Web of Science ®Google Scholar
• Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010;19(5):698-711
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012;13(10):679-92
   PubMed Web of Science ®Google Scholar
• Knapp S, Weinmann H. Small-molecule modulators for epigenetics targets. ChemMedChem 2013;8(11):1885-91
   PubMed Web of Science ®Google Scholar
• Yoo J, Medina-Franco JL. Chemoinformatic approaches for inhibitors of DNA methyltransferases: comprehensive characterization of screening libraries. Comp Mol Biosci 2011;1:7-16
   Google Scholar
• Bender A, Jenkins JL, Scheiber J, et al. How similar are similarity searching methods? A principal component analysis of molecular descriptor space. J Chem Inf Model 2009;49(1):108-19
   PubMed Web of Science ®Google Scholar